Fresh Tracks Therapeutics Inc (FRTX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Robert B. Brown
Employees:
20
5777 CENTRAL AVENUE, SUITE 102, BOULDER, CO, 80301
(720) 505-4755
-
Formally known as:
- BRICKELL BIOTECH ORD SHS
Date | Ratio |
---|---|
2016-05-27 | 1:10 |
2019-09-03 | 1:7 |
2022-07-05 | 1:45 |
Brickell Biotech, Inc. engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofironium bromide, which has completed Phase III clinical trials for the. treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor, and BBI10, a covalent stimulator of interferon genes inhibitor.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|